A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808 (T808)
A Phase 0, Open Label, Non-Randomized, Multi-Center, Exploratory and Safety Study of [F-18]T808
Sponsor: Avid Radiopharmaceuticals
Terminated
Study was terminated in anticipation of transfer of ownership to Avid Radiopharmaceuticals.
Other terminated trials from Avid Radiopharmaceuticals
Other Alzheimers Disease trials with similar outcome
This EARLY_PHASE1 trial investigates Alzheimers Disease and is currently terminated or withdrawn. Avid Radiopharmaceuticals leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated EARLY_PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated EARLY_PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Terminated EARLY_PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Terminated EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated Phase 0
First recorded
Jul 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Avid Radiopharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .